ITCC-081 Idasanutlin
A PHASE I/II, MULTICENTER, OPEN-LABEL, MULTI-ARM STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ACTIVITY OF IDASANUTLIN
Promotor Name : Genentech
Investigator Name : B. GEOERGER
Trial registered on clinicaltrial.gov : NCT04029688
